The Cefriaxone Injection, cataloged under National Stock Number 6505-01-364-3779, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 6 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-364-3779 |
| Item Name | Cefriaxone Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | BOTTLE |
| Active Medicament Medicinal Strength | 1.000 GRAMS CEFTRIAXONE EQUIVALENT G |
| Total Primary Container Quantity | 24 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Reference | Meaning |
|---|---|
| 2G3524 | 3/9 Design control — primary reference Baxter Healthcare Corp |
| NDC00004-2002-78 | 5/9 Secondary reference Baxter Healthcare Corp |
NSN 6505-01-364-3779 is a Cefriaxone Injection, classified under FSC 6505, Drugs and Biologicals. Status: active.
Key specifications for 6505-01-364-3779: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 50.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: BOTTLE. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.